European Archives - Page 976 of 1109 - European Medical Journal

EMJ Hematology 4 [Suppl 9] 2016

The 11th New Horizons in Haematology (NHH11) conference was moderated by Dr Sarah Jarvis, healthcare reporter and television presenter…

Advancing Our Clinical Perspectives in Haematology: What Is Your Approach?

The 11th New Horizons in Haematology (NHH11) conference was moderated by Dr Sarah Jarvis, healthcare reporter and television presenter, and was delivered…

EAN 2016 – Prof Günther Deuschl

Prof Gunther Deuschl’s press conference at EAN 2016.EMJ Neurology 4.1 2016 coming soon, subscribe for free today!

EAN 2016 – Prof John England – Part 2

Part 2 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…

EAN 2016 – Prof Raad Shakir – Part 1

Part 1 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…

EAN 2016 – Prof Mads Henrik Ravnborg

Prof Mads Henrik Ravnborg’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!

EAN 2016 – Prof Franz Fazekas

Prof Franz Fazekas’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!

EAN 2016 – Prof Gunhild Waldemar

Prof Gunhild Waldemar’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!

EMJ

Overview of ZPL-3893787 (ZPL-389) clinical trial for atopic dermatitis

Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, gives an overview of a phase 2a proof-of-concept clinical trial evaluating ZPL…

EMJ

Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis

Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…